Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44)

The summary for the Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44): The Division of Comparative Medicine (DCM), Office of Research Infrastructure Programs (ORIP), supports Resources that create, develop, preserve and supply a variety of high-quality animal models and related biological materials to the biomedical community. DCM-supported Resources and the research community will benefit from development and commercialization of technologies that support the husbandry, characterization, improvement and use of animal models and related biological materials. This Funding Opportunity Announcement (FOA) encourages small business concerns to submit Small Business Innovation Research (SBIR) grant applications that propose innovative approaches to further develop, improve and facilitate the use of animal models and related biological materials to meet new biomedical challenges related to improvements in the health of humans and animals.

Federal Grant Title:	Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-13-092
Type of Funding:	Grant
CFDA Numbers:	93.351
CFDA Descriptions:	Research Infrastructure Programs
Current Application Deadline:	Jan 07, 2016
Original Application Deadline:	Jan 07, 2016
Posted Date:	Jan 25, 2013
Creation Date:	Jan 25, 2013
Archive Date:	Feb 07, 2016
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (...; • Development of Animal Models and Related Biological Materials for Research (R21 Clinical T...; • Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not All...; • Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Transl...; • Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed); • Development of novel and emerging technologies for the accurate detection and diagnosis of...; • Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of...; • Shared Instrumentation Grant Program (S10)
More Grants from the National Institutes of Health: • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...; • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...; • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)